Oral Abstract Session:
218. Resistance is Futile
Saturday, October 29, 2016: 10:30 AM-12:00 PM
Room: 288-290

Learning Objectives:

.

Tracks: Adult ID

Moderators:  Cesar Arias, MD, PhD, FIDSA, Univ. El Bosque and Thomas Lodise, PharmD, PhD, Albany College of Pharmacy

Presentations:
10:30 AM
Rapid Emergence of Ceftazidime-avibactam (C/A) Resistance due to blaKPC-3 Mutations during Treatment (tx) of Carbapenem-resistant Klebsiella pneumoniae (CRKp) Infections
Ryan K. Shields, PharmD ; Liang Chen, PhD ; Shaoji Cheng, PhD ; Kalyan Chava, PhD ; Barry N. Kreiswirth, PhD ; Ellen G. Press, MS ; Minh-Hong Nguyen, MD ; Cornelius J. Clancy, MD
10:43 AM
Clinical and molecular evidence of Atovaquone resistance in Babesia microti infection associated with Rituximab
Matthew S. Simon, MD, MS ; Lars Westblade, PhD ; Richard Furman, MD ; Audrey Schuetz, MD ; Stephen Jenkins, PhD ; Laura Kirkman, MD
10:56 AM
Identification of Patients at Greatest Risk for Carbapenem Resistance in Patients With Serious Hospital-Onset Infections Due to Enterobacteriaceae Species
Thomas P. Lodise, PharmD, PhD ; Michael Ye, MS ; Katelyn R. Keyloun, PharmD, MS ; Qi Zhao, MD, MPH ; Patrick Gillard, PharmD, MS
11:09 AM
Quantitative Responses of Taxonomic Composition and Resistance Gene Abundance in the Gut Microbiota to Fecal Microbiota Transplantation
Amy Langdon, BA ; Christopher Bulow, BA ; Kimberly Reske, MPH ; Xiaoqing Sun, MS ; Tiffany Hink, BS ; Courtney Jones, BS ; Carey-Ann D. Burnham, PhD ; Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA ; Gautam Dantas, PhD
11:22 AM
Does Timing of Receipt of Appropriate Antimicrobial Therapy Make a Difference Among Patients with Serious Infections due to Resistant Gram-negative Pathogens?
Ariel Berger, MPH ; Tarun Bhagnani, MS ; Rosa Wang, MHA ; Qi Zhao, MD, MPH ; Michael Ye, MS ; Thomas P. Lodise, PharmD, PhD
11:35 AM
The Impact of Infectious Diseases Consultations on Multi-Drug Resistant Gram-Negative Infections
Eris Cani, BS, PharmD ; Jessica Yager, MD, MPH ; Stanley Moy, PharmD, BCPS ; Roopali Sharma, BS, PharmD, AAHIVP, BCPS (AQ-ID)
11:48 AM
The Meaning of Isolating ESBL Enterobacteriaceae From The Urine of Pregnant Women, a Matched Case Control Study
Yael Yagel, MD ; Hilli Nativ, MD ; Klaris Riesenberg, MD ; Lior Nesher, MD ; Lisa Saidel-Odes, MD ; Abraham Borer, MD ; Rozalia Smolyakov, MD

CME Credits: No CME credit is offered for this session.

ACPE Credits:

ACPE Number:


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.